Crossmark

Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2025-004963

Published Online: 2025-11-09

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Chen, Angela Xun-Nan

Radhakutty, Anjana

Thompson, Campbell

Burt, Morton G
Funding

Funding for this research was provided by:

National Institute for Dementia Research (GNT1189788)

National Heart Foundation of Australia (NHF102453)
License Information

License valid from 2025-11-09